Evidence map›Paper›PMID 34388477›Full record

ArticleCytokine2021

Cancer-related cognitive impairment is associated with perturbations in inflammatory pathways.

Kate Oppegaard, Carolyn S Harris, Joosun Shin, Steven M Paul, Bruce A Cooper, Alexandre Chan, Joaquin A Anguera, Jon Levine, Yvette Conley, Marilyn Hammer and 3 more

Open access · greenAbstract read
In one paragraph

Article in Cytokine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 1 pooled it
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 1 synthesis or guideline pooled it, 38 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Cancer treatment-related cognitive impairment.Neuro-oncology advances · 2026
    Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Immune checkpoint inhibition perturbs neuro-immune homeostasis and impairs cognitive function.Journal of experimental & clinical cancer research : CR · 2025
    Article
  13. Observational
  14. Incidence and predictors of immune checkpoint inhibitor treatment-related cognitive impairment in a racial and ethnic diverse population.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025
    Article
  15. Article
  16. Perturbations in the neuroactive ligand-receptor interaction and renin angiotensin system pathways are associated with cancer-related cognitive impairment.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025
    Article
  17. Article
  18. Article
  19. Article
  20. Anxiety in oncology outpatients is associated with perturbations in pathways identified in anxiety focused network pharmacology research.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 2 countries.

Kate OppegaardSchool of Nursing, University of California, 2 Koret Way - N631Y, San Francisco, CA 94143-0610, USA. Electronic address: kate.oppegaard@ucsf.edu.
Carolyn S HarrisSchool of Nursing, University of California, 2 Koret Way - N631Y, San Francisco, CA 94143-0610, USA. Electronic address: carolyn.harris@ucsf.edu.
Joosun ShinSchool of Nursing, University of California, 2 Koret Way - N631Y, San Francisco, CA 94143-0610, USA. Electronic address: joosun.shin@ucsf.edu.
Steven M PaulSchool of Nursing, University of California, 2 Koret Way - N631Y, San Francisco, CA 94143-0610, USA. Electronic address: steven.paul@ucsf.edu.
Bruce A CooperSchool of Nursing, University of California, 2 Koret Way - N631Y, San Francisco, CA 94143-0610, USA. Electronic address: bruce.cooper@ucsf.edu.
Alexandre ChanSchool of Pharmacy and Pharmaceutical Sciences, University of California Irvine, 147B Bison Modular, Irvine, CA 92697, USA. Electronic address: a.chan@uci.edu.
Joaquin A AngueraSchool of Medicine, University of California, 675 Nelson Rising Lane, San Francisco, CA 94158, USA. Electronic address: joaquin.anguera@ucsf.edu.
Jon LevineSchool of Medicine, University of California, 675 Nelson Rising Lane, San Francisco, CA 94158, USA; School of Dentistry, University of California, 513 Parnassus Ave, MSB, San Francisco, CA 94117, USA. Electronic address: jon.levine@ucsf.edu.
Yvette ConleySchool of Nursing, University of Pittsburgh, 440 Victoria Building, 3500 Victoria Street, Pittsburgh, PA 15261, USA. Electronic address: yconley@pitt.edu.
Marilyn HammerDana-Farber Cancer Institute, 450 Brookline Avenue, LW523, Boston, MA 02215, USA. Electronic address: marilynj_hammer@dfci.harvard.edu.
Christine A MiaskowskiSchool of Nursing, University of California, 2 Koret Way - N631Y, San Francisco, CA 94143-0610, USA; School of Medicine, University of California, 675 Nelson Rising Lane, San Francisco, CA 94158, USA. Electronic address: chris.miaskowski@ucsf.edu.
Raymond J ChanCaring Futures Institute, College of Nursing and Health Sciences, Flinders University, Bedford Park SA5042, Australia. Electronic address: Raymond.Chan@flinders.edu.au.
Kord M KoberSchool of Nursing, University of California, 2 Koret Way - N631Y, San Francisco, CA 94143-0610, USA. Electronic address: kord.kober@ucsf.edu.
University of California, San Francisco · USDana-Farber Cancer Institute · USFlinders University · AUUniversity of California, Irvine · USUniversity of Pittsburgh · US

Funding

Symptoms Clusters in Oncology Patients Receiving ChemotherapyR01CA134900 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI AOUIZERAT, BRADLEY E, MIASKOWSKI, CHRISTINE A. · 2009 to 2014
$5.9M
Biobehavioral Research Training Program in Symptom ScienceT32NR016920 · NINR · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MIASKOWSKI, CHRISTINE A., WEISS, SANDRA JEAN · 2017 to 2021
$2.4M
NCI NIH HHS R01 CA134900NINR NIH HHS T32 NR016920
6 · The paper itself

Abstract

Cancer-related cognitive impairment (CRCI) is a significant problem for patients receiving chemotherapy. While a growing amount of pre-clinical and clinical evidence suggests that inflammatory mechanisms underlie CRCI, no clinical studies have evaluated for associations between CRCI and changes in gene expression. Therefore, the purpose of this study was to evaluate for differentially expressed genes and perturbed inflammatory pathways across two independent samples of patients with cancer who did and did not report CRCI. The Attentional Function Index (AFI) was the self-report measure used to assess CRCI. AFI scores of <5 and of >7.5 indicate low versus high levels of cognitive function, respectively. Of the 185 patients in Sample 1, 49.2% had an AFI score of <5 and 50.8% had an AFI score of >7.5. Of the 158 patients in Sample 2, 50.6% had an AFI score of <5 and 49.4% had an AFI score of >7.5. Data from 182 patients in Sample 1 were analyzed using RNA-seq. Data from 158 patients in Sample 2 were analyzed using microarray. Twelve KEGG signaling pathways were significantly perturbed between the AFI groups, five of which were signaling pathways related to inflammatory mechanisms (e.g., cytokine-cytokine receptor interaction, tumor necrosis factor signaling). This study is the first to describe perturbations in inflammatory pathways associated with CRCI. Findings highlight the role of cytokines both in terms of cytokine-specific pathways, as well as pathways involved in cytokine production and cytokine activation. These findings have the potential to identify new targets for therapeutics and lead to the development of interventions to improve cognition in patients with cancer.

Indexed as

Signal TransductionAttentionCognitive DysfunctionFemaleGene Expression ProfilingGene Expression RegulationHumansInflammationLogistic ModelsMaleMiddle AgedNeoplasmsRNA-SeqTumor Necrosis Factor-alphaTumor Necrosis Factor-alphaCancer-related cognitive impairmentChemotherapyGene expressionIL-17 signaling pathwayMAPK signaling pathway

Identifiers

PMID34388477
PMCPMC10792770
OpenAlexW3192317589

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.